AstraZeneca’s Baxdrostat Shows Phase 3 Success in Hypertension

September 2, 2025

FDA Regulatory Challenges for Biotech Companies: What Leaders Need to Know

March 18, 2026

J&J’s Autoimmune Drug Prospect Meets Phase 3 Goal, Inches Closer to Approval

February 7, 2024

Must Read

Is Green Biotech the Future of Sustainable Drug Development?

May 6, 2026

Amgen Adds $300 Million to Puerto Rico Expansion, Bringing U.S. Investment Commitments Near $2 Billion

May 6, 2026

Gedatolisib from Celcuity outperforms Piqray from Novartis in phase 3 research

May 6, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Gedatolisib from Celcuity outperforms Piqray from Novartis in phase 3 research

Takeda Reports Phase 2/3 Data Showing TAK-881 Comparable to HyQvia in Primary Immunodeficiency Disease

In a late-stage trial, Intellia’s gene treatment for rare condition reduces swelling attacks

Boehringer Reports Phase 3 Data on Survodutide Showing 16.6% Weight Loss at Week 76

Amgen Adds $300 Million to Puerto Rico Expansion, Bringing U.S. Investment Commitments Near $2 Billion

Chiesi to Acquire KalVista for $1.9 Billion, Adding Oral HAE Therapy Ekterly

Teva Pens Deal Worth Over $700M to Buy Emalex

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Is Green Biotech the Future of Sustainable Drug Development?

Top 10 High-Impact Careers Defining the Future of Life Sciences

Top 10 Pharma Companies Leading Innovation in Drug Development (2026)

Top 10 Breakthrough Therapies Shaping the Future of Medicine (2026)

Commercial

Gilead gives Arcellx $285 million to extend agreement for BCMA cell treatment

Editor Picks

AstraZeneca’s Baxdrostat Shows Phase 3 Success in Hypertension

FDA Regulatory Challenges for Biotech Companies: What Leaders Need to Know

J&J’s Autoimmune Drug Prospect Meets Phase 3 Goal, Inches Closer to Approval

Must Read

Is Green Biotech the Future of Sustainable Drug Development?

Amgen Adds $300 Million to Puerto Rico Expansion, Bringing U.S. Investment Commitments Near $2 Billion

Gedatolisib from Celcuity outperforms Piqray from Novartis in phase 3 research

Hot Topics

About Us

Follow Us